Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma-Reference-Cited by-同舟云学术

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Published:2018-08-02 Issue:5 Volume:379 Page:417-427
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Méjean Arnaud¹,Ravaud Alain¹,Thezenas Simon¹,Colas Sandra¹,Beauval Jean-Baptiste¹,Bensalah Karim¹,Geoffrois Lionnel¹,Thiery-Vuillemin Antoine¹,Cormier Luc¹,Lang Hervé¹,Guy Laurent¹,Gravis Gwenaelle¹,Rolland Frederic¹,Linassier Claude¹,Lechevallier Eric¹,Beisland Christian¹,Aitchison Michael¹,Oudard Stephane¹,Patard Jean-Jacques¹,Theodore Christine¹,Chevreau Christine¹,Laguerre Brigitte¹,Hubert Jacques¹,Gross-Goupil Marine¹,Bernhard Jean-Christophe¹,Albiges Laurence¹,Timsit Marc-Olivier¹,Lebret Thierry¹,Escudier Bernard¹

Affiliation:

1. From the Departments of Urology (A.M., M.-O.T.) and Medical Oncology (S.O.), Hôpital Européen Georges-Pompidou, Assistance Publique–Hôpitaux de Paris (AP-HP), Université Paris–Descartes, and Paris Descartes Necker–Cochin Clinical Research Unit, AP-HP (S.C.), Paris, the Department of Medical Oncology, Bordeaux University Hospital (A.R.), the Department of Medical Oncology, Hôpital Saint André, Centre Hospitalier Universitaire (CHU) de Bordeaux (M.G.-G.), and the Department of Urology, CHU de Bordeaux and...

Funder

Pfizer

Programme Hospitalier de Recherche Clinique Cancer

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1803675

Cited by 661 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis;Immunopharmacology and Immunotoxicology;2024-02-06

2. The role of radiation therapy for de novo metastatic bladder and renal cancers;Cancer/Radiothérapie;2024-02

3. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review;World Journal of Urology;2024-01-20

4. Beyond the knife: strategic patient selection for cytoreductive nephrectomy;Current Opinion in Urology;2024-01-19

5. Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002;European Urology Oncology;2024-01